#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Crigler-Najjar syndrome Skin angiosarcoma Postprandial hypoglycaemia Neuromyelitis optica spectrum disorder Myasthenia gravis Osteosarcoma Laryngeal squamous cell carcinoma Chronic inflammatory demyelinating polyradiculoneuropathy Neuroendocrine carcinoma metastatic Fabry's disease Sickle cell anaemia Bronchopulmonary dysplasia Kaposi's sarcoma Sickle cell disease Metastases to central nervous system More trials…

    Learn about Rare Diseases

    Castleman’s disease – Diagnostics Idiopathic inflammatory myopathy – Trials in Disease Methylmalonic acidaemia – Trials in Disease Rhabdoid tumour Propionic acidaemia – Life with Disease Ornithine transcarbamoylase deficiency – Basic Information Turner’s syndrome – Trials in Disease Progressive supranuclear palsy – Treatment Glycogen storage disease type V – Life with Disease Pituitary-dependent Cushing’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ADS-019 ENSIFENTRINE Balcinrenone Antithymocyte Immunoglobulin NALOXEGOL Enomimeran Ampreloxetine D-Camphor Pervi-Neo Amantadine Hemisulfate Methohexital Sodium Imiglucerase Feladilimab Mecillinam Nandrolone Decanoate Idarubicin Alrefimotide Inclisiran Gad20-209-Fsp-A4 L-PHENYLALANINE More therapies…

    Learn about Your Condition

    Mantle cell lymphoma stage IV Small cell lung cancer Vulval cancer Retinitis pigmentosa Drug eruption Kearns-Sayre syndrome Bile duct cancer Bladder cancer stage II Vulvovaginal pruritus Thermal burn Coronary artery dissection Lung adenocarcinoma stage III Stress urinary incontinence Hypotonia Solitary fibrous tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study of hyperthermic intraperitoneal chemotherapy with oxaliplatin, fluorouracil, and calcium levofolinate in patients with advanced gastric cancer after surgery

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Calcium Levofolinate
    • Fluorouracil
    • Oxaliplatin
    France

  • Study on the Safety and Effects of Tulisokibart for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Tulisokibart
    Czechia France Poland

  • Study on the Effects of Amlitelimab for Adults with Non-Responsive Celiac Disease

    Not recruiting

    2 1
    Investigated Drugs:
    • Amlitelimab
    Belgium Czechia Finland France Germany Greece +6

  • Long-term safety study of filgotinib tablets in adults with ulcerative colitis who completed previous filgotinib treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Filgotinib
    Hungary

  • Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    4 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Etrasimod Arginine
    Austria Belgium Bulgaria Croatia Czechia Denmark +9

  • Study on Preventing Recurrent Pouchitis in Ulcerative Colitis Patients Using Fecal Microbiota Transplant and Sodium Chloride

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Enteritis
    Investigated Drugs:
    • Allogeneic Faecal Microbiota
    • Sodium Chloride
    France
Previous Page
1 … 67 68 69 70 71 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!